¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³â Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö : 2023-11-10

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³â Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö : 2023-11-10
±³À°ÀÏÀÚ : 2023-11-10
±³À°Àå¼Ò : °¡Å縯´ëÇб³ Omnibus Park convention hall

±³À°ÁÖÁ¦ : 2023³â Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸  

´ã´çÀÚ : ±èÀÎÁ¤
¿¬¶ôó : 02-741-8540

À̸ÞÀÏ : kalc@lungca.or.kr

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 80,000¿ø  

ºñ°í »çÀüµî·Ï ȸ¿ø: 50,000¿ø/ ºñȸ¿ø 70,000¿ø ÇöÀåµî·Ï ȸ¿ø: 60,000¿ø/ ºñȸ¿ø 80,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 09:00~09:20 Immunologic perspective of immune cold tumor non-squamous vs squamous Yoon Park(KIST)

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 09:20~09:40 Clinical categories of cold tumor among lung cancer: Genetic correlations Hyo Sup Shim(Yonsei University)

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 09:40~10:00 Vaccine and non-vaccine strategy to convert cold to hot tumors vaccine and conceptual therapeutics (ADC, bispecific, myeloid targeting) Beung-Chul Ahn(National Cancer Center)

Åä·Ð 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 10:00~10:20 Q&A ()

ÈÞ½Ä 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 10:20~10:40 Coffee Break ()

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 10:40~11:00 SCLC subtypes and implication to immunotherapy Sehhoon Park(Sungkyunkwan University)

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 11:00~11:20 Immune checkpoint inhibitors for SCLC Jang Ho Cho(Catholic University)

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 11:20~11:40 Novel antibody therapeutics for SCLC Tae Min Kim(Seoul National University)

Åä·Ð 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 11:40~12:00 Q&A ()

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 12:00~12:40 Perioperative chemo-immunotherapy for resectable NSCLC Teru-Fumi Kato (Kanagawa Cancer Center)

ÈÞ½Ä 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 12:40~13:00 Coffee Break ()

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 13:00~13:20 Resectability should be changed with neoadjuvant chemo-immunotherapy? Samina park(Seoul National University)

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 13:20~13:40 Promising result and future challenges for perioperative chemo-immunotherapy Gyeong-Won Lee(Gyeongsang National University)

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 13:40~14:00 Biomarker analysis of perioperative chemo-immunotherapy Si-Hyong Jang(Soonchunhyang University)

Åä·Ð 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 14:00~14:20 Q&A ()

ÈÞ½Ä 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 14:20~14:40 Coffee Break ()

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 14:40~15:00 Benefit and limitations of IO in mesothelioma Nivo+Ipi, CAR-T Hee Kyung Ahn (Gachon University)

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 15:00~15:20 Heterogeneity and its implications in IO for thymic malignancies Sunhee Chang(Inje University)

±³À°½Ã°£ 11¿ù 10ÀÏ Catholic University of Korea Omnibus Park convention hall 15:20~15:40 Novel immunotherapeutics for thoracic malignancies specific ADC, bispecific data Sun Min Lim(Yonsei University)

Åä·Ð 11¿ù 10ÀÏ 15:40~16:00 Q&A ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³â Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö : 2023-11-10""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ³×Æ®¿öÅ©¸ÞŸºÐ¼®À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©¼¥ : 2023-11-10
´ÙÀ½±Û ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ) ê GPT ½Ã´ë, ÀÇ·á ÀΰøÁö´É°ú ÀÇ»çÀÇ ¿ªÇÒ : 2023-11-09
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
15 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-29 0 688 2018-07-28
14 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø ¿µ»óȹµæÀÇ ±â¼úÀû Ãø¸é°ú Æó¾Ï °ËÁø : 2018-07-29 0 733 2018-07-28
13 ¼­¿ï ´ëÇѺÎÀÎÁ¾¾çÇÐȸ KGOG 2018 Summer Workshop Uterine Cancer : 2018-07-29 0 861 2018-07-28
12 ¼­¿ï ´ëÇÑ¿µ»óÀÇÇÐȸ »ó±ÙÀÇ»ç À¯¹æÃÔ¿µ¿ëÀåÄ¡ Ç°Áú°ü¸® ±³À° 3ÀÏÂ÷(7¿ù29ÀÏ) : 2018-07-29 0 796 2018-07-28
11 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-29 0 813 2018-07-28
10 ¼­¿ï °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Á¦ 18 ȸ ü°èÀû ¹®Çå °íÂû[¸ÞŸºÐ¼®]À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©¼¥ : 2018-07-28 0 1,146 2018-07-28
9 °æ±â ¸íÁöº´¿ø ¿äÃò ¹× ½½°üÀý ÅëÁõ Ä¡·áÀÇ ÃÖ½ÅÁö°ß : 2018-07-28 0 1,100 2018-07-28
8 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-28 0 1,046 2018-07-28
7 ¼­¿ï ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ 2018³â ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ ¿¬¼ö°­Á : 2018-07-28 0 980 2018-07-28
6 °æ±â ´ëÇѳ»½Ã°æº¹°­°æ¿Ü°úÇÐȸ 2018 Pressurized Intra Peritoneal Aerosol Chemotherapy (PIPAC) Symposium : 2018-07-28 0 1,226 2018-07-28
5 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø Hyperhidrosis Symposium : 2018-07-28 0 1,514 2018-07-28
4 ¼­¿ï °¡Å縯´ëÇб³¿©Àǵµ¼º¸ðº´¿ø 2018 The 11th Catholic Neurosurgery Update Symposium : 2018-07-28 0 1,389 2018-07-28
3 °æ±â ´ëÇÑ´ç´¢º´ÇÐȸ °æÀÎÁöȸEGDM (Essential Guideline to Diabetes Management) : 2018-07-28 0 2,201 2018-07-28
2 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-28 0 1,424 2018-07-28
1 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ¼ºÇü¿Ü°ú °­³² Áý´ãȸ : 2018-07-28 0 1,977 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷